| Literature DB >> 34310736 |
Srinidhi Sudharson1,2, Tanja Kalic1,2, Christine Hafner1, Heimo Breiteneder2.
Abstract
The WHO/IUIS Allergen Nomenclature Database (http://allergen.org) provides up-to-date expert-reviewed data on newly discovered allergens and their unambiguous nomenclature to allergen researchers worldwide. This review discusses the 106 allergens that were accepted by the Allergen Nomenclature Sub-Committee between 01/2019 and 03/2021. Information about protein family membership, patient cohorts, and assays used for allergen characterization is summarized. A first allergenic fungal triosephosphate isomerase, Asp t 36, was discovered in Aspergillus terreus. Plant allergens contained 1 contact, 38 respiratory, and 16 food allergens. Can s 4 from Indian hemp was identified as the first allergenic oxygen-evolving enhancer protein 2 and Cic a 1 from chickpeas as the first allergenic group 4 late embryogenesis abundant protein. Among the animal allergens were 19 respiratory, 28 food, and 3 venom allergens. Important discoveries include Rap v 2, an allergenic paramyosin in molluscs, and Sal s 4 and Pan h 4, allergenic fish tropomyosins. Paramyosins and tropomyosins were previously known mainly as arthropod allergens. Collagens from barramundi, Lat c 6, and salmon, Sal s 6, were the first members from the collagen superfamily added to the database. In summary, the addition of 106 new allergens to the previously listed 930 allergens reflects the continuous linear growth of the allergen database. In addition, 17 newly described allergen sources were included.Entities:
Keywords: WHO/IUIS Allergen Nomenclature Database; allergen discovery; allergen protein families; novel food allergens; novel respiratory allergens
Mesh:
Substances:
Year: 2021 PMID: 34310736 PMCID: PMC9290965 DOI: 10.1111/all.15021
Source DB: PubMed Journal: Allergy ISSN: 0105-4538 Impact factor: 14.710
FIGURE 1Protein superfamilies/families with the highest numbers of allergens defined from 01/2019 to 03/2021. Ribbon representations of available structures from homologues of the new allergens. Prolamin superfamily: nsLTP (PDB accession number: 7KSC, organism: Punica granatum), 2S albumin (5DOM, Moringa oleifera). CAP superfamily: PR‐1 (1SMB, Homo sapiens), venom allergen 5 (1QNX, Vespula vulgaris). Triosephosphate isomerase family: triosephosphate isomerase from Litopenaeus vannamei (5EYW). EF‐hand family: myosin light chain (3I5F, Todarodes pacificus), beta‐parvalbumin (5CPV, Cyprinus carpio), sarcoplasmic calcium‐binding protein (2SCP, Hediste diversicolor), troponin C (1A2X, Oryctolagus cuniculus). Profilin family: profilin from Cucumis melo (6MBX). Molecular graphics were done with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco
Overview of respiratory allergens included in the ANDB from 01/2019 to 03/2021
| No. | Species | Allergen name | Type of protein | Allergy profile of the patients recruited | Allergenicity tests | Reference |
|---|---|---|---|---|---|---|
| 1 |
| Amb t 8 | Profilin | Ragweed PA (n=198) | POS ELISA in 85/198 subjects with rAmb t 8 | ANDB |
| 2 |
| Art ab 1 | DPLP | Mugwort PA (n=11) with IgE reactivity to Art v 1 | POS SPT, ELISA, WB, RAST in 11/11 patients to natural Art ab 1 and POS BAT in 4/4 patients | Pablos et al., |
| 3 |
| Art an 1.0101 | DPLP | POS ELISA, WB, RAST in 11/11 patients to natural Art an 1 and POS BAT in 4/4 patients | ||
| 4 | Art an 1.0102 | DPLP | PA (n=23) | POS ImmunoCAP in 16/23 subjects with purified Art an 1 and rArt an 1 | ANDB | |
| 5 | Art an 2 | PR‐1 | PA (n=29) | POS ImmunoCAP in 24/29 subjects with purified Art an 1 and rArt an 2 | ||
| 6 | Art an 3 | nsLTP | PA (n=28) | POS ImmunoCAP in 14/28 subjects with rArt an 3 | ||
| 7 |
| Art ar 1 | DPLP | PA (n=18) | POS ELISA and ImmunoCAP in 14/18 individuals with purified Art ar 1 and rArt ar 1 | |
| 8 | Art ar 3 | nsLTP | PA (n=26) | POS ImmunoCAP in 15/26 subjects with Art ar 3 | ||
| 9 |
| Art c 1 | DPLP | PA (n=11) | POS IgE‐binding in 11/11 subjects with Art c 1, POS BAT in 4/4 subjects | |
| 10 |
| Art ca 1 | DPLP | PA (n=25) | POS ImmunoCAP in 17/25 subjects with Art ca 1 | |
| 11 | Art ca 2 | PR‐1 | PA (n=21) | POS ImmunoCAP in 9/21 subjects with Art ca 2 | ||
| 12 | Art ca 3 | nsLTP | PA (n=28) | POS ImmunoCAP in 14/28 subjects with Art ca 3 | ||
| 13 |
| Art f 1 | DPLP | Mugwort PA (n=11) with IgE reactivity to Art v 1 | POS ELISA, WB in 11/11 patients and POS BAT in 4/4 patients to natural Art f 1 | Pablos et al., |
| 14 |
| Art gm 1 | DPLP | PA (n=20) | POS ELISA in 13/20 subjects with natural Art gm 1 | ANDB |
| 15 | Art gm 2 | PR‐1 | PA (n=29) | POS ImmunoCAP in 24/29 subjects with Art gm 2 | ||
| 16 | Art gm 3 | nsLTP | PA (n=26) | POS ImmunoCAP in 15/26 subjects with Art gm 3 | ||
| 17 |
| Art l 1 | DPLP | Mugwort PA (n=11) with IgE reactivity to Art v 1 | POS ELISA, WB in 11/11 individuals with natural Art l 1 and POS BAT in 4/4 patients | Pablos et al., |
| 18 |
| Art la 1 | DPLP | PA (n=20) | POS ELISA in 13/20 subjects with natural Art la 1 | ANDB |
| 19 | Art la 2 | PR‐1 | PA (n=21) | POS ImmunoCAP in 8/21 subjects with Art la 2 | ||
| 20 | Art la 3 | nsLTP | PA (n=27) | POS ImmunoCAP in 16/27 individuals with Art la 3 | ||
| 21 |
| Art si 1 | DPLP | PA (n=18) | POS ELISA in 14/18 subjects with rArt si 1 | |
| 22 | Art si 2 | PR‐1 | PA (n=20) | POS ImmunoCAP in 14/20 patients with Art si 2 | ||
| 23 | Art si 3 | nsLTP | PA (n=20) | POS ImmunoCAP in 14/20 patients with Art si 3 | ||
| 24 |
| Art t 1 | DPLP | Mugwort PA (n=11) with IgE reactivity to Art v 1 | POS ELISA, WB in 11/11 individuals and POS BAT in 4/4 patients to natural Art t 1 | Pablos et al., |
| 25 |
| Asp t 36 | TIM | Individuals with late summer conjunctivitis and rhinitis, and SPT POS to mugwort extract were recruited in the study. | Karmakar et al., | |
| 26 |
| Bla g 12 | Chitinase | Patients sensitized to cockroach based on ImmunoCAP and SPT (n=23) | POS ImmunoCAP in 7/23 patients with rBla g 12 | ANDB |
| 27 |
| Can f 8 | Cystatin | Dog‐allergic patients (n=113) | POS ELISA in 15/113 patients with rCan f 8 | |
| 28 |
| Can s 2 | Profilin | Cannabis‐allergic patients (n=45) | POS CBA in 5/45 patients and POS MAT with rCan s 2 | Ebo et al., |
| 29 | Can s 4 | Oxygen‐evolving enhancer protein 2 | Patients with immediate symptoms on cannabis exposure (n=113) | POS ImmunoCAP and BAT in 8/113 and 3/3 individuals respectively with the allergen | Decuyper et al., | |
| 30 | Can s 5 | PR‐10 homologue | Cannabis‐allergic patients (n=45) | POS CBA in 35/45 patients and POS MAT with rCan s 5 | Ebo et al.26 | |
| 31 |
| Cry j 7 | GRP | Cypress pollen‐sensitized subjects diagnosed with peach allergy (n=54), consecutive cypress pollinosis subjects unselected with respect to peach allergy (n=88) were recruited in study | POS ImmunoCAP in 16/16 individuals with Cry j 7 | Ehrenberg et al., |
| 32 |
| Cup s 7 | GRP | Cypress PA with POS IgE‐binding to Pru p 7 and/or Pun g 7 | POS FABER test in 16/31 subjects with Cup s 7 | Tuppo et al., |
| 33 |
| Der f 37 | Chitin binding protein | Asthmatic patients (n=192) | POS ELISA in 41/192 individuals and POS WB, DB in 4/10 subjects | ANDB |
| 34 | Der f 38 | Bacteriolytic enzyme | HDM‐allergic patients (n=30) | POS SPT in 8/30 patients with rDer f 38 | ||
| 35 | Der f 39 | Troponin C | Rhinitis or asthma patients (n=76) | POS ELISA in 7/76 subjects and POS WB, DB in 7/7 and 6/7 subjects respectively | ||
| 36 | Der f 5 | n.a. | Mite‐allergic patients were recruited (n=192) | ANDB | ||
| 37 |
| Der p 25 | TIM | Perennial respiratory allergic and HDM‐allergic individuals (n=26) | POS ELISA in 14/26 subjects with rDer p25 | Liu et al., |
| 38 | Der p 26 | Myosin light chain | POS ELISA in 16/26 subjects with rDer p26 | |||
| 39 | Der p 28 | Heat shock protein 70 | POS ELISA in 18/26 subjects with rDer p28 | |||
| 40 | Der p 29 | Cyclophilin | Perennial respiratory allergic and HDM‐allergic patients (n=26) recruited in the study | |||
| 41 | Der p 30 | Ferritin | ||||
| 42 | Der p 31 | Cofilin | ||||
| 43 | Der p 32 | Inorganic pyrophosphatase | Perennial respiratory allergic and HDM‐allergic individuals (n=26) | POS ELISA in 12/26 subjects with rDer p32 | ||
| 44 | Der p 33 | Alpha‐tubulin | POS ELISA in 17/26 subjects with rDer p33 | |||
| 45 | Der p 38 | Bacteriolytic enzyme | Patients (n=40) | POS SPT, IgE‐binding in 18/40, 31/40 individuals with rDer p 38 and POS BAT in 3/3 individuals | ANDB | |
| 46 |
| Jun a 7 | GRP | Cypress pollen‐sensitized subjects diagnosed with peach allergy (n=54), consecutive cypress pollinosis subjects unselected with respect to peach allergy (n=88) | POS ImmunoCAP in 16/16 patients to the allergen | Ehrenberg et al., |
| 47 |
| Mor a 2 | Cobalamin‐independent methionine synthase | Subjects that are SPT POS to mulberry extract and with inhalation allergy (n=11) | POS WB seen in 11/11 subjects with the allergen | ANDB |
| 48 |
| Phl p 3 | Expansin‐like protein | Grass PA were recruited (n=70) | ||
| 49 |
| Pop n 2 | Profilin | Patients with symptoms of allergic rhinitis and SPT POS to | POS IB in 13/20, 11/20 subjects to naturally purified Pop n 2 and rPop n 2 respectively | Shams et al., |
| 50 |
| Que ac 1 | PR‐10 | Pollen‐allergic patients (n=24) | POS ELISA and WB in 22/24 individuals with rQue ac 1 | ANDB |
| 51 | Que ac 2 | Profilin | Pollen allergic subjects (n=50) | POS RAST observed in 6/50 individuals with rQue ac 1 | ||
| 52 |
| Que i 1 | PR‐10 | Patients that are SPT POS to Holly oak (n=38) | POS IB in 21/38 patients with rQue i 1 | Pedrosa et al., |
| 53 |
| Que m 1 | PR‐10 | Patients that are SPT POS to Mongolian oak extract (n=50) | POS ELISA and BAT in 46/50 and 3/35 subjects respectively with rTyr p 1 | Lee et al., |
| 54 |
| Tyr p 1 | Cysteine protease | Patients with asthma, rhinitis, AD or eczema (206), 106/206 were sensitized to | POS ELISA in 65/106 patients with rTyr p 1 |
Yu et al., |
| 56 | Tyr p 7 | Bactericidal permeability‐increasing protein | Patients with asthma, rhinitis, AD or eczema (206), 106/206 were sensitized to | POS ELISA in 40/106 patients with rTyr p 7 | ||
| 55 | Tyr p 20 | Arginine kinase | Patients with asthma, rhinitis, AD or eczema (206), 106/206 were sensitized to | POS ELISA in 51/106 patients with rTyr p 20 | ||
| 57 | Tyr p 8 | GST | Storage mite‐allergic patients were used in the study (n=10) | ANDB | ||
| 58 |
| Zoy m 1 | Pollen expansin | Grass PA (n=57) | POS ELISA, WB in 14/57 patients to rZoy m 1 | |
Abbreviations: AD, atopic dermatitis; BAT, basophil activation test; CBA, cytometric bead array; DB, dot blot; ELISA, enzyme‐linked immunosorbent assay; FABER®, friendly allergen nano‐bead array; IB, immunoblot; MAT, mast cell activation test; PA, pollen‐allergic patients; POS, positive; RAST, radioallergosorbent test; SPT, skin prick test; WB, Western blot.
Overview of food allergens included in the ANDB from 01/2019 to 03/2021
| No. | Species | Allergen name | Type of protein | Allergy profile of the patients recruited | Allergenicity tests | Reference |
|---|---|---|---|---|---|---|
| 1 |
| Ara h 18 | Cyclophilin ‐ peptidyl‐prolyl cis‐trans isomerase | Peanut‐sensitized subjects (n=15) | POS IgE‐binding in 13/15 subjects for rArah18 | ANDB |
| 2 |
| Asc l 5 | Divalent cation binding protein | Children from the “Risk Factors for Asthma and Allergy in the Tropics” (FRAAT) cohort (n=254) and all‐age subjects from Santa Catalina (SC) cohort (n=298) | POS IgE‐binding in 81/254 subjects in FRAAT cohort and 155/298 subjects in SC cohort with the allergen | Ahumada et al., |
| 3 |
| Bos d 13 | Myosin light chain | Beef‐allergic patients (n=30) | POS ELISA in 8/30 patients to rBos d 13 | ANDB |
| 4 |
| Cal b 2 | Arginine kinase | Crab‐allergic patients (n=12) | POS WB in 8/12 subjects to Cal b 2 | |
| 5 |
| Cari p 2 | Cysteine protease | Papaya‐allergic patients (n=10) | POS SPT in 3/3 patients, POS RBL in 6 patients with rCari p 2 | |
| 6 |
| Cic a 1 | Group 4 late embryogenesis abundant protein | Subjects with clinical reactions following chickpea ingestion (n=38) | POS IB in 7/36 patients with rCic a 1 | Wangorsch et al., |
| 7 |
| Cor a 15 | Oleosin | Food‐allergic patients (n=26) | POS SPT in 30/30 subjects and POS IgE‐binding in 17/26 with natural Cra a 4 and rCra a 4 | ANDB |
| 8 |
| Cra a 4 | Sarcoplasmic calcium‐binding protein | Oyster‐sensitized subjects (n=10) | POS WB and DB in 10/10 patients with the allergen | Han et al., |
| 9 |
| Cten i 1 | Beta‐parvalbumin | IgE‐mediated allergy against grass carp (n=69), confirmed grass carp allergy by food challenge (n=16) | POS ELISA in 69/69 patients to native Cten i 1 | Leung et al., |
| 10 |
| Cuc ma 4 | 11S globulin | Subjects allergic to pumpkin seeds (n=4) | POS WB in 4/4 subjects | Bueno‐Díaz et al., |
| 11 | Cuc ma 5 | 2S albumin | Subjects allergic to pumpkin seeds (n=4) | POS WB in 2/4 subjects | ||
| 12 |
| Cyp c 2 | Beta‐enolase | Fish‐allergic patients (n=29) | POS SPT in 24/29 patients with extract and ELISA/DB POS in 5/29 patients with rCyp c 2 | ANDB |
| 13 |
| Fag t 6 | Oleosin | Buckwheat‐allergic patients (n=20) | POS ELISA,WB and DB in 12/20 subjects with Fag t 6 | |
| 14 |
| Lat c 6 | Collagen alpha | Fish‐allergic patients (n=101) | POS ELISA in 21/101 patients with purified collagen | Kalic et al., |
| 15 |
| Lin u 1 | 2S albumin | Patients that experienced previous anaphylaxis due to flax seed ingestion (n=2) | POS SPT, IB in 2/2 patients with Lin u 1 | Basagaña Torrentó et al., |
| 16 |
| Lup an 3 | nsLTP | Study group of individuals with different allergy profiles (n=31) | Lupine sensitization detected by ImmunoCAP and SPT | Jappe et al., |
| 17 |
| Mac i 1 | Vicilin | Macadamia nut‐allergic patients (n=8) | POS ELISA in 4/8 patients with Mac i 1 | ANDB |
| 18 | Mac i 2 | Legumin | Macadamia nut‐allergic patients (n=8) | POS ELISA in 6/8 with Mac i 2 | ||
| 19 |
| Pan h 1 | Beta‐parvalbumin | IgE‐mediated allergy symptoms after fish ingestion in children, SPT POS to commercial salmon and in‐house catfish preparations (n=77) | IgE‐binding to heat labile and heat stable salmon and catfish proteins was analyzed in the patients | Ruethers et al., |
| 20 | Pan h 10 | L‐lactate dehydrogenase | ||||
| 21 | Pan h 11 | Glucose‐6‐phosphate isomerase | ||||
| 22 | Pan h 13 | Glyceraldehyde‐3‐phosphate dehydrogenase | ||||
| 23 | Pan h 2 | Beta‐enolase | ||||
| 24 | Pan h 3 | Aldolase A | ||||
| 25 | Pan h 4 | Tropomyosin alpha | ||||
| 26 | Pan h 7 | Creatin kinase | ||||
| 27 | Pan h 8 | TIM | ||||
| 28 | Pan h 9 | Pyruvate kinase PKM‐like | ||||
| 29 | Pen m 13 | Fatty acid binding protein | Patients with history of allergy to | POS ELISA in 20/30 subjects and POS BAT in 7/12 subjects with rPen m 13 | ANDB | |
| 30 | Pen m 8 | TIM | Patients with history of allergy to | POS ELISA in 12/30 subjects with rPen m 8and POS BAT in 2/12 subjects | ||
| 31 |
| Pru ar 5 | Acidic protein Hev b 5‐like | Patients with Hev b 5 allergy and apricot allergy (n=5) | POS FABER test in all 5 subjects | |
| 32 |
| Pru av 7 | GRP | Sweet cherry‐allergic patients (n=25) | POS BAT and IgE‐binding in 11/25 patients with Pru av 7 | |
| 33 |
| Pru du 10 | Mandelonitrile lyase 2 | Patients with allergic reactions following almond ingestion (n=18) | POS sensitization in 12/18 patients with Pru du 10 | Kabasser et al., |
| 34 |
| Pun g 14 | Chitinase III | Subjects with history of allergic reactions to pomegranate fruit and/or POS SPT (n=10) | POS DB in 5/10 subjects and POS IB in 8/10 patients with Pun g 14 | Tuppo et al., |
| 35 |
| Rap v 2 | Paramyosin | Snail‐allergic subjects (n=5) and controls (n=3) | POS WB, DB in 5/8 subjects | C. Yu et al., |
| 36 |
| Sal s 4 | Tropomyosin | IgE‐mediated allergy symptoms after fish ingestion in children, SPT POS to commercial salmon and in‐house catfish preparations (n=77) | IgE‐binding to heat labile and heat stable salmon and catfish proteins was analyzed in the patients | Ruethers et al., |
| 37 | Sal s 6 | Collagen alpha | ||||
| 38 | Sal s 7 | Creatine kinase | ||||
| 39 | Sal s 8 | TIM | ||||
| 40 | Sal s 9 | n.a. | n.a. | n.a. | ANDB | |
| 41 |
| Scy p 1 | Tropomyosin | Crab‐allergic subjects (n=10) | POS ELISA with Scy p 1, rScy p 1, and mutant Scy p 1 | G. Y. Liu et al., |
| 42 | Scy p 3 | Myosin light chain | Crab‐sensitized subjects(n=10) | Immunogenicity analyzed by DB, BAT with rScy p 3 | M. S. Li et al., | |
| 43 | Scy p 9 | Filamin C | Crustacean‐allergic patients (n=100) | POS ELISA, WB, DB in 30/100 subjects with Scy p 9 and rScy p 9 | ANDB | |
| 44 |
| Sola m 1 | Profilin | Eggplant‐allergic patients confirmed with SPT and ImmunoCAP (n=36) | POS IB in 36/36 subjects with rSola m 1 and POS BAT in 6/6 subjects | Maity et al., |
Abbreviations: BAT, basophil activation test; CBA, cytometric bead array; DB, dot blot; ELISA, enzyme‐linked immunosorbent assay; FABER®, friendly allergen nano‐bead array; IB, immunoblot; n.a., not available; POS, positive; SPT, skin prick test; WB, Western blot.